Lynn Hunt, from the UK, Initially thought she had just ‘bitten’ her tongue when two little white spots appeared on the side, ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

Full House alum Dave Coulier posted a photo of himself undergoing chemotherapy, two days after sharing that he was battling ...

A study published inClinical Cancer Research found that in patients with unresectable, locally advanced esophageal cancer, ...

During a Case-Based Roundtable® event, Patrick M. Forde, MD, discussed safety and tolerability concerns with immunotherapy in ...

In patients with unresectable, locally advanced esophageal cancer, the triple combination of radiation, chemotherapy, and immunotherapy made tumors more amenable to surgery, which was associated with ...

Yanghee Woo, MD, discusses the details and lasting impact of the CROSS trial in the treatment of gastroesophageal junction ...

Aaron Whittington was young, fit and healthy when he was diagnosed. Picture: Lachie Millard But after there was no ...

Should you invest in Bicara Therapeutics Inc? Click for more on BCAX's promising cancer treatment, but proceed with caution ...

Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adultsCosibelimab PDUFA goal date of December 28 for ...

both under Phase 2 clinical study for treating head and neck squamous cell carcinoma. Receive News & Ratings for ALX Oncology ...